We are live on
!
Find out more
MCM
Marsico Capital Management Portfolio holdings
AUM
$3.4B
1-Year Est. Return
51.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$11.3B
AUM Growth
-$536M
(-4.5%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-6.38%
Top 10 Holdings %
Top 10 Hldgs %
44.21%
Holding
104
New
17
Increased
29
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$232M |
| 2 |
Electronic Arts
EA
|
+$162M |
| 3 |
Salesforce
CRM
|
+$118M |
| 4 |
Bausch Health
BHC
|
+$90.4M |
| 5 |
Zoetis
ZTS
|
+$87.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$265M |
| 2 |
Biogen
BIIB
|
+$215M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$190M |
| 4 |
Union Pacific
UNP
|
+$158M |
| 5 |
Alibaba
BABA
|
+$148M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.72% |
| 2 | Communication Services | 19.78% |
| 3 | Technology | 14.98% |
| 4 | Consumer Discretionary | 12.37% |
| 5 | Financials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYCC
51
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $31.6M | 0.28% |
1,321,612
-55,240
| -4% | -$1.22M |
|
52
Citigroup
C
$230B
| $31.3M | 0.28% |
566,381
-18,316
| -3% | -$996K |
|
53
O'Reilly Automotive
ORLY
$74.9B
| $28.8M | 0.25% |
1,909,350
-388,590
| -17% | -$5.76M |
|
54
Regeneron Pharmaceuticals
REGN
$78.3B
| $27.7M | 0.24% |
54,347
-1,669
| -3% | -$815K |
|
|
FRC
55
DELISTED
First Republic Bank
FRC
| $27.7M | 0.24% |
439,823
+70,698
| +19% | +$4.28M |
|
56
Medtronic
MDT
$110B
| $26.4M | 0.23% |
356,181
-14,888
| -4% | -$1.14M |
|
57
Domino's
DPZ
$12.2B
| $25.8M | 0.23% |
227,595
-18,960
| -8% | -$2.04M |
|
58
SBA Communications
SBAC
$19.9B
| $24.5M | 0.22% |
212,687
-6,531
| -3% | -$766K |
|
59
Burlington
BURL
$23.2B
| $24M | 0.21% |
468,632
+138,524
| +42% | +$7.4M |
|
60
Lockheed Martin
LMT
$136B
| $23.9M | 0.21% |
128,708
-595,963
| -82% | -$115M |
|
61
Eli Lilly
LLY
$995B
| $22.5M | 0.2% |
+269,500
| New | +$20.5M |
|
62
CME Group
CME
$94.4B
| $22.3M | 0.2% |
239,843
+37,057
| +18% | +$3.46M |
|
|
BEAV
63
DELISTED
B/E Aerospace Inc
BEAV
| $21.4M | 0.19% |
389,000
-27,131
| -7% | -$1.61M |
|
|
NLSN
64
DELISTED
Nielsen Holdings plc
NLSN
| $21M | 0.19% |
469,934
+43,420
| +10% | +$1.97M |
|
65
Starwood Property Trust
STWD
$6.03B
| $20.5M | 0.18% |
949,989
+60,010
| +7% | +$1.42M |
|
66
Crown Castle
CCI
$33.9B
| $20.2M | 0.18% |
251,637
+32,745
| +15% | +$2.73M |
|
67
DexCom
DXCM
$32.8B
| $20.1M | 0.18% |
1,007,068
+182,420
| +22% | +$3.2M |
|
|
PARA
68
DELISTED
Paramount Global Class B
PARA
| $19.8M | 0.17% |
355,957
-92,189
| -21% | -$5.57M |
|
69
Ryanair
RYAAY
$31.2B
| $19.7M | 0.17% |
673,623
+46,323
| +7% | +$1.29M |
|
70
Novartis
NVS
$291B
| $18.4M | 0.16% |
209,173
| – | – |
|
71
CoStar Group
CSGP
$12.1B
| $17.9M | 0.16% |
890,770
-27,330
| -3% | -$557K |
|
|
HOT
72
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $17.4M | 0.15% |
214,573
-7,539
| -3% | -$631K |
|
73
Acadia Healthcare
ACHC
$2.95B
| $15.2M | 0.13% |
+194,196
| New | +$14M |
|
74
Element Solutions
ESI
$9.48B
| $14.6M | 0.13% |
+570,731
| New | +$15.4M |
|
|
GWR
75
DELISTED
Genesee & Wyoming Inc.
GWR
| $13M | 0.12% |
171,292
-80,758
| -32% | -$7.11M |
|
Similar funds
BG
OAM
DFO
VFCM
CIA
EFM
JGC
PWP
Marsico Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Marsico Capital Management held 104 positions worth $11.3B, down 4.5% from $11.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Marsico Capital Management withdrew a net $722M in Q2 2015, closing 13 positions and reducing 44 holdings. Its most notable exit was Gilead Sciences, an estimated $265M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Marsico Capital Management opened a new position in Zoetis worth $88.2M.
- Marsico Capital Management's largest Q2 2015 buy was Zoetis: 1,828,140 shares worth $88.2M.
- Marsico Capital Management added most to Illumina in Q2 2015, an estimated $232M increase.
- Marsico Capital Management's biggest Q2 2015 reduction was Biogen, cutting an estimated $215M.
- Marsico Capital Management fully exited Gilead Sciences in Q2 2015, selling an estimated $265M.
- Marsico Capital Management's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2015.
- Marsico Capital Management opened 17 new positions and closed 13 in Q2 2015.
- Marsico Capital Management's portfolio value fell 4.5% quarter-over-quarter to $11.3B.
Based on Marsico Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.